People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Computers, Other Technology, Other, Software / Tech, AI / ML
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ICERTIS, Inc. | — | Computers | Series C | $368.3M | $402.5M | 2016 |
| Ocient Inc. | — | Other Technology | Series C | $183.5M | $333.2M | 2021 |
| Botkeeper Inc. | — | Other Technology | Series C | $84.8M | $882.1M | 2018 |
| Movieclips, Inc. | — | Other Technology | Series B | $72.7M | $152.3M | 2011 |
| Machinima Inc | — | Other | Series B | $65.5M | $207.7M | 2009 |
| Clozd, Inc. | — | Other Technology | Series B | $35.8M | $504.6M | 2022 |
| Safi Analytics PBC | — | Software / Tech | Series B | $17.1M | $370.3M | 2021 |
| Blueboard Inc. | — | Other | Series A | $16.4M | $135.0M | 2018 |
| Netuitive Inc | — | Computers | Series A | $16.3M | $216.0M | 2010 |
| Tinderbox, Inc. | — | Other Technology | Series A | $15.5M | $131.8M | 2016 |
| Sybill Inc. | — | Other Technology | Series A | $14.4M | $87.7M | 2024 |
| Solfo, Inc. | — | Computers | Series A | $11.0M | $153.3M | 2013 |
| Ocient Holdings LLC | — | Other Technology | Series A | $10.9M | $31.3M | 2021 |
| DramaFever Corp. | — | Other Technology | Series A | $9.2M | $69.4M | 2012 |
| Leena AI, Inc. | — | AI / ML | Series A | $7.7M | $241.5M | 2020 |
| BlueX Trade, Inc. | — | Other | Seed | $4.2M | $18.1M | 2020 |
| AwesomenessTV, Inc. | — | Other | Seed | $3.5M | $65.1M | 2012 |
| Generate Holdings Inc | — | Other | Seed | $2.0M | $37.2M | 2009 |
Mark Terbeek at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Terbeek on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.